Apellis Pharmaceuticals Inc (APLS) Technical Analysis
$25.23▲1.08%
Market is closed - opens 8 PM, 15 Dec 2025
Insights
- Apellis Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Apellis Pharmaceuticals stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Apellis Pharmaceuticals stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Apellis Pharmaceuticals stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 68.46 | Sell |
Stochastic | 95.18, 95.18 | Sell |
Ultimate Oscillator | 66.13 | Neutral |
Stochastic Relative Strength Index | 100.0, 99.93 | Neutral |
Moving Average Convergence Divergence | 0.69, 0.06 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 23.14 | Buy |
20 | 21.71 | Sell |
50 | 23.11 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 23.5 | Buy |
20 | 22.66 | Sell |
50 | 22.73 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 23.12 | Buy |
20 | 21.66 | Buy |
50 | 22.97 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 24.86 | Buy |
20 | 23.31 | Buy |
50 | 22.29 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 25.51 | Buy |
20 | 24.54 | Buy |
50 | 21.87 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 26.48 |
Resistance L2 | 26.0 |
Resistance L1 | 25.48 |
Pivot Point | 25.0 |
Support L1 | 24.49 |
Support L2 | 24.01 |
Support L3 | 23.49 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.